Microbot Medical (MBOT) said Monday it plans to sell about 6.1 million shares at $2.13 apiece in a registered direct offering and 12.2 million shares at the same price in a concurrent private placement.
The offerings are expected to close by Tuesday, the company said.
Gross proceeds from these offerings are estimated at about $13 million. The plans to use net proceeds to advance its Liberty Robotic System, explore new applications based on its intellectual properties, and support working capital and general corporate needs, it added.
Shares of the company were down over 18% in recent trading.
Price: 2.09, Change: -0.47, Percent Change: -18.24
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.